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Introduction {#sec1}
============

Approximately 5 million Americans older than 50 years suffer from dry eye disease, with a significant number of cases linked to decreased tear production from the lacrimal gland (LG), an exocrine organ responsible for secreting the aqueous layer of the tear film ([@bib22], [@bib47]). Treatments to reduce tear loss for aqueous deficient dry eye disease (ADDE) include anti-inflammatory drugs, artificial tears, or punctal occlusion ([@bib18], [@bib33], [@bib34], [@bib39]). However, a major limitation of these therapies is that they treat the symptoms of ADDE, rather than the underlying etiology. Regenerative therapies that target LG repair, or the development of bioengineered tissues, have been recently reported ([@bib16], [@bib20]), although our understanding of LG biology is still incomplete. For example, it is not known how different cell populations arise during development and how they are maintained throughout life, and the identification and functional analysis of LG stem and progenitor cells has yet to be carried out. When this knowledge is translated to the clinic, it will enhance regenerative approaches that are currently being undertaken ([@bib5], [@bib16], [@bib20]).

Murine LG development begins at embryonic day (E) 13.5, as an outgrowth of conjunctival tissue that progressively elongates toward the ear ([@bib23], [@bib28]). The primitive gland undergoes branching at E16.5 to form the intra- and extra-ocular structures ([@bib14]). Branching continues during both embryonic and post-natal development, and the gland becomes functionally mature at approximately postnatal day (P) 30 ([@bib45]). Recently, embryonic lineage analysis using the constitutive K14-Cre43 (also known as Tg(KRT14-cre)43Smr) mouse line ([@bib46]) suggested that LG morphogenesis follows a similar developmental process to other branched organs (prostate and mammary gland), making the LG a fitting model to study general glandular development ([@bib23]). Furthermore, others ([@bib12]) have also attempted to follow the epithelial cell lineage during LG development using inducible mouse lines; however, clonal analysis and long-term cell fate mapping was not performed in this study.

In both mice and humans, the adult mammalian LG contains both mesenchymal and epithelial cells, with the latter composed of three major lineages: the acinar cells, ductal cells, and myoepithelial cells (MECs) ([@bib26], [@bib51], [@bib52]). MECs express α-smooth muscle actin (αSMA) and contract to modulate the secretory function of the acinar cells ([@bib1], [@bib4], [@bib9], [@bib11], [@bib17], [@bib19], [@bib31], [@bib35]). The secretory acini are connected to ducts, which are composed of a basal and a luminal layer, that modify tear composition before it is secreted onto the ocular surface ([@bib26], [@bib31]).

We have recently demonstrated that a population of c-kit^+^dim/EpCAM^+^/Sca1^−^/CD34^−^/CD45^−^ cells displayed the greatest number of progenitor hallmarks, which reinstated LG function following grafting into a damaged recipient gland ([@bib16]). Although analysis of stem cell (SC) localization and function has been performed in mammary ([@bib32], [@bib36], [@bib43]) and salivary glands ([@bib8], [@bib49]), the study of stem and progenitor cells in the LG is incomplete. There are two competing hypotheses regarding the origin of stem/progenitor cells in adult LGs: one postulates that a common multipotent (able to give rise to all epithelial lineages) stem/progenitor cell exists, whereas the second proposes that unipotent acinar, ductal, and MEC lineages are derived from lineage-specified SCs ([@bib26], [@bib51]).

In the current study, we address how cell lineages are established in the adult LGs and whether multipotent or unipotent SCs exist during postnatal development, homeostasis, and regeneration. To achieve this, we combined lineage tracing in specific Cre reporter mouse strains (Krt14, Runx1, and αSMA) with *in vivo* analysis of infrequently dividing cells using a histone 2B (H2B)-GFP label retention system ([@bib29]) expressed under control of the keratin 5 (Krt5) promoter. We established that the embryonic LG epithelium contains a unique long-lived cell population composed of undifferentiated, multipotent. and highly plastic progenitor cells that give rise to all postnatal epithelial cell types. Furthermore, our study demonstrates that LG morphogenesis during early postnatal development is driven by long-lived multipotent and unipotent embryonic progenitor cells, whereas the adult LG is maintained by long-lived and short-lived unipotent lineage-restricted stem/progenitor cells. These cells may contribute to LG renewal during homeostasis and/or regeneration. We also show that lineage-specific MECs retain a certain level of plasticity in the adult LG and are able to trans-differentiate into acinar cells following LG injury. The longevity of the unipotent lineage-restricted cells and their ability to participate in tissue regeneration suggests the universal plasticity of these and possibly other cell types in the LG. Our study suggests a model where injury/acute inflammation activates proliferation of the existing lineage-restricted progenitors, which is then continued by slowly proliferating long-term common reserve progenitor cells and their progenies. Our findings provide important new concepts, while revealing differences in the homeostatic and regenerative potential of stem and progenitor cells in LGs.

Results {#sec2}
=======

Slow-Cycling Label-Retaining Cells Are Localized in the Basal Layer of the Lacrimal Gland Intra- and Interlobular Ducts and Intercalated Ducts {#sec2.1}
----------------------------------------------------------------------------------------------------------------------------------------------

Two unique properties of SCs are quiescence (label retention hypothesis) and longevity (the capacity to form long-lived clones). The ability to retain a DNA label is a common feature among SCs from several adult tissues including cornea, sweat, salivary, and lacrimal glands ([@bib8], [@bib10], [@bib24], [@bib48], [@bib50]). To detect label-retaining cells (LRCs) in the LG, we employed the H2B-GFP pulse-chase labeling system ([Figure 1](#fig1){ref-type="fig"}A). After the 28-day pulse phase, H2B-GFP/K5tTA mice were fed a doxycycline-containing diet for 30 days (4 weeks) and 56 days (8 weeks) to shut off H2B-GFP expression and dilute the GFP by 50% with every cell division ([Figure 1](#fig1){ref-type="fig"}A). Before the chase ([Figures S1](#mmc1){ref-type="supplementary-material"}A--S1C), GFP was found in almost all MECs ([Figure S1](#mmc1){ref-type="supplementary-material"}E, MEC: 92.5% ± 4.3%) and intercalated ducts ([Figure S1](#mmc1){ref-type="supplementary-material"}E, ID: 98.1% ± 2.0%) and in the majority of basal ductal cells ([Figure S1](#mmc1){ref-type="supplementary-material"}E, BD: 89.5% ± 9.3%). A small number of GFP-labeled luminal ductal cells was also found ([Figures S1](#mmc1){ref-type="supplementary-material"}E and S1E′, LUM: 3.3% ± 2.7%). No labeling of acinar cells was detected ([Figures S1](#mmc1){ref-type="supplementary-material"}A--S1C and S1E). Following a 4-week chase, LRCs were observed in the basal epithelium of all inter- and intra-lobular ducts (35% ± 5%), as determined by Thrombospondin-1 (Thsp1) immunostaining ([Figure 1](#fig1){ref-type="fig"}B), which labels luminal ductal cells ([@bib16]), and in MECs (4.1% ± 0.9%), as determined by αSMA expression ([Figure 1](#fig1){ref-type="fig"}C, white arrows). Observing a subpopulation of LRCs within MECs suggests the presence of slow-cycling progenitor cells within the MEC lineage.Figure 1Krt5^+^ Label-Retaining Cells (LRCs) Reside in the Ductal EpitheliumTwelve LGs per time point have been analyzed.(A) Schematic of the experimental approach.(B) After 30 days of doxycycline (DOX) administration labeled cells (green) were found in the basal layer of the ducts. They were not located in luminal cells (luminal cells were identified by Thrombospondin-1 antibody staining: red).(C) GFP-labeled cells (green) were also found in a small subset of MECs marked by anti-αSMA staining (red).(D--G) (D) After 8 weeks of doxycycline chase, LRCs (green) are found only in the basal ductal (*duct*) cells and intercalated duct cells (*id,* white arrow). Basal ductal cells also expressed c-kit (E: gray, also see [Figure S2](#mmc1){ref-type="supplementary-material"}), Krt14 (F: gray, also see [Figure S3](#mmc1){ref-type="supplementary-material"}), and Sox9 (G, G': green arrows).(H--K) LRCs exhibited variations in GFP fluorescence intensities. LRCs and other ductal cells were quantified on 3D reconstructions generated by immunofluorescence tomography. (H) Quantification of LRCs with different fluorescence intensities. (I--K) An index of label retention was used to visualize the range of GFP expression within cells of the reconstructed images. (I and J) Examples of single sections though LG duct. (K) Reconstraction of LG ducts. Cells were grouped according to level of GFP expression and are represented as high level, red (LRC^+++^); medium level, yellow (LRC^++^); low level, green (LRC^+^); and no GFP expression, blue (non-LRC).See also [Figures S1--S3](#mmc1){ref-type="supplementary-material"}.

After an 8-week chase there was complete depletion of the GFP signal in MECs, and LRCs were only found in a subset of basal cells of the intra-lobular, excretory, and intercalated ducts ([Figure 1](#fig1){ref-type="fig"}D). These ductal LRCs expressed Krt5 ([Figure S1](#mmc1){ref-type="supplementary-material"}F), c-kit ([Figures 1](#fig1){ref-type="fig"}E and [S2](#mmc1){ref-type="supplementary-material"}), Krt 14 ([Figures 1](#fig1){ref-type="fig"}F, [S1](#mmc1){ref-type="supplementary-material"}G, S1H, and [S3](#mmc1){ref-type="supplementary-material"}), and the embryonic progenitor cell marker Sox9 ([Figures 1](#fig1){ref-type="fig"}G and 1G′). Sox9 expression was observed in all ductal and MEC cells of adult glands ([Figures 1](#fig1){ref-type="fig"}G and 1G′), whereas Sox10 expression, similar to embryonic LG ([@bib7]), was observed in the distal LG compartments: acinar cells and MECs ([Figures S1](#mmc1){ref-type="supplementary-material"}I--S1K).

Following the chase periods, we quantified the fluorescence intensity of LRCs using 3-dimensional reconstructions of immunofluorescence tomography scans (n = 3, 323 ± 38 μm^3^) ([Figures 1](#fig1){ref-type="fig"}H--1K) and cells were grouped based on their GFP expression (see [Methods](#sec4){ref-type="sec"}): high level of GFP expression, red (LRC^+++^); medium level, yellow (LRC^++^); low level, green (LRC^+^); and no GFP expression, blue (non-LRC) ([Figures 1](#fig1){ref-type="fig"}I--1K). Using this system of indexing cells, we observed 1% ± 0.28% LRC^+++^, 6% ± 0.13% LRC^++^, and 9% ± 0.2% LRC^+^ from the total cells within a field of view ([Figure 1](#fig1){ref-type="fig"}H). Cells with the highest GFP expression (LRC^+++^) following the 8-week chase were deemed to be quiescent stem/progenitor population. These data indicate that there are at least two sources of slow-cycling LRCs in the LG: within the basal cells of inter- and intra-lobular ducts and a subset of cells in the intercalated ducts.

Lineage Tracing Using the Confetti Mouse Demonstrates the Existence of LG Krt14^+^ Multipotent Progenitor Cells during Early Postnatal Development {#sec2.2}
--------------------------------------------------------------------------------------------------------------------------------------------------

Analysis of Krt5 and Krt14 expression patterns ([Figure S4](#mmc1){ref-type="supplementary-material"}) demonstrated that although their expression pattern may not completely overlap ([Figure S4](#mmc1){ref-type="supplementary-material"}), both keratins were expressed in the same cellular compartments of LG: MEC and basal ductal cells. As Krt5 and Krt14 were expressed in the same cellular compartments, we utilized the K14^CreERT2^-Confetti mouse to trace the Krt14 cell lineage. Mice were administered tamoxifen (TM) during early postnatal development (at P7), and their LGs were examined 1, 3, 8, and 30 weeks later ([Figure 2](#fig2){ref-type="fig"}). After a 1-week chase, Krt14^+^ cells were found in the basal layer of inter- and intra-lobular excretory and intercalated ducts, and MECs ([Figures 2](#fig2){ref-type="fig"}A and 2B). Co-immunostaining with αSMA antibody revealed that in addition to MECs, a subset of αSMA^+^ cells was present within the basal layer of excretory interlobular ducts ([Figure 2](#fig2){ref-type="fig"}C, orange arrows, [Figure S5](#mmc1){ref-type="supplementary-material"}), whereas some of basal ductal cells were αSMA^−^ (white arrows). Phalloidin staining supported this observation and showed that some cells in the basal layer of LG ducts contain filamentous actin ([Figures S6](#mmc1){ref-type="supplementary-material"}A and S6B). Large amount of filamentous actin was also present in the apical parts of the ductal luminal cells ([Figures S6](#mmc1){ref-type="supplementary-material"}A and S6B). Thus, luminal and some of the basal ductal cells may have a contractile function to assist in tear release.Figure 2Lineage Tracing of Krt14^+^ Cells in the LGs of the *Krt14*^*CreERT2*^*:R26-Confetti* Mice (Also See [Figure S4](#mmc1){ref-type="supplementary-material"})(A--L) TM was administrated at P7, and LGs were analyzed 1 week (A--C), 3 weeks (D and E), 8 weeks (F--I), and 30 weeks (J--L) later.(A and B) 1-week chase: labeled cells were found in the basal layer of excretory ducts (A: GFP is nuclear \[green, green arrows\], YFP is cytoplasmic \[pale green, yellow arrows\], dsRed is cytoplasmic \[red, red arrows\]) and majority of MECs. Note: No labeling was observed in acinar cells.(C) 1-week chase: immunostaining of LG for αSMA reveals a subset of αSMA^+^ (αSMA^+^, orange arrows) cells within the basal layer of excretory ducts. However, some of basal ductal cells were αSMA^−^ (white arrows, also see [Figure S5](#mmc1){ref-type="supplementary-material"}).(D and E) Analysis of labeled MECs induced by tamoxifen administration at P7 after a 3-week chase. Clonal expansion of MECs (D) and basal ductal cells is apparent after a 3-week (E) chase period.(F--I) Analysis of labeled MECs induced by tamoxifen administration at P7 after an 8-week chase. Clonal expansion of MECs (F) and basal ductal cells (G and H) is observed. (I) After an 8-week chase, rare single acinar cells were observed (white arrows).(J) Acinar cells formed small clones after a 30-week chase (white arrows).(K--M) (K) Expansion of basal ductal cells (white arrows) and MECs after a 30-week chase. Labeled luminal cells in the excretory ducts (L) and intercalated ducts (M) were observed after a 30-week chase.(N) Clonal expansion of Krt14^+^ cells during postnatal development and homeostasis. LGs obtained from *Krt14*^*CreERT2*^*:R26-Confetti* male mice were analyzed at different time points (3--5 glands per time point). Clonal analysis was performed within each cellular compartment. Thus, ductal cells were classified as luminal or basal based on their position, morphology, and nuclear shape. Clonal size was determined separately within each of these compartments (for example, measured clone sizes in each ductal compartment include only basal cells or only luminal cells). Clonal size is represented by the number of cells per clone ± SD, p \< 0.05, one-way ANOVA. Mean is blue, SD is red.(O) Comparison of cell-labeling efficiency in the LGs during postnatal development and adulthood. The proportion of labeled basal ductal and MECs was compared with unlabeled basal ductal or MECs cells. Cells were labeled in postnatal development at P7 or in adulthood at P30 (percent of labeled cells ± SD; basal ducal cells p = 0.2531, MECs p = 0.1044; two-tailed t test). No significant difference between number of labeled cells in postnatal development and adulthood was observed. See also [Figures S4--S6](#mmc1){ref-type="supplementary-material"}.

Analysis of Krt14-labeled cells after a 3-week chase detected clonal expansion of MECs ([Figures 2](#fig2){ref-type="fig"}D), 4.3 ± 0.5 cells per clone ([Figure 2](#fig2){ref-type="fig"}N). After an 8- ([Figures 2](#fig2){ref-type="fig"}F and 2N) and 30-week chase ([Figure 2](#fig2){ref-type="fig"}N), the number of MECs in clones continue to increase (6.1 ± 3.5 cells per clone after 8-weeks of chase and 14.6 ± 16.1 cells per clone after a 30-week chase). This finding suggests that MEC population may contain a subset of long-lived proliferating progenitor cells. Krt14^+^ clones were also found within the basal layer of ducts at 3 weeks ([Figures 2](#fig2){ref-type="fig"}E and 2N), 4.3 ± 2.1 cells per clone; 8 weeks ([Figures 2](#fig2){ref-type="fig"}G, 2H, and 2N), 5.6 ± 3.6 cells per clone; and 30 weeks of chase ([Figures 2](#fig2){ref-type="fig"}N), 10.8 ± 7.4 cells per clone, also suggesting that the basal ductal cell population may harbor long-lived progenitors.

We did not observe labeling of acinar cells before an 8-week chase, at this stage only detecting rare single Krt14^+^ acinar (1.4 ± 0.5 cells per clone; [Figures 2](#fig2){ref-type="fig"}I and 2N) cells. Thirty-weeks after TM administration, we observed small numbers of acinar cell clones (5.2% ± 4.3%; [Figures 2](#fig2){ref-type="fig"}J and 2N). Similarly, a few single labeled luminal ductal cells were found after a 3- and 8-week chase ([Figure 2](#fig2){ref-type="fig"}N), whereas after a 30-week chase labeled luminal cells formed small clones (5.0 ± 2.8 cells per clone) ([Figures 2](#fig2){ref-type="fig"}L and 2N). Labeling of intercalated duct cells (2.2% ± 0.8%) was observed only after a 30-week chase ([Figure 2](#fig2){ref-type="fig"}M). The rare labeling of acinar and luminal ductal cells in the intra-lobular and intercalated ducts could be explained by the small number of labeled bi- or multipotent stem/progenitor cells present in the LG during postnatal development, low cell replacement rate in these lineages, or Krt14 lineage restriction during early postnatal LG development.

Interestingly, TM administration to adult (cells were labeled at P30 and analyzed at P90) Krt14^CreERT2^: Confetti mice revealed labeling of only MECs and basal ductal cells. No luminal ductal or acinar cells were observed at 8- or 30-week chase times. A comparison of the proportion of labeled basal ductal and MECs in the LG of mice labeled at P7 and P30 showed that cells in basal ductal and MEC compartments of young and adult mice were labeled with similar efficiency ([Figure 2](#fig2){ref-type="fig"}O). This suggests that the efficiency of TM-induced reporter expression during LG postnatal development and adulthood was similar.

Analysis of SMA^+^ MECs Reveal Their Proliferation and Self-Renewal during Postnatal Development and Early Adulthood {#sec2.3}
--------------------------------------------------------------------------------------------------------------------

As Krt14 expression was found in MECs, we could not rule out the possibility that the MEC lineage contains multipotent SCs capable of occasionally differentiating into acinar or ductal cells. We administered TM to *SMA*^*CreERT2:*^*R26-Confetti* mice at P14 (when MECs differentiate) and analyzed their LGs following various chase periods ([Figure 3](#fig3){ref-type="fig"}A). Labeling efficiency using R26-Confetti during postnatal development was determined as 46% ± 5%, p \< 0.05 ([Figure 3](#fig3){ref-type="fig"}B). Clonal analysis following a 1-week chase period revealed mosaic labeling of single cells, with rare clones consisting of 1--4 cells (1.5 ± 0.7, p \< 0.0001) ([Figures 3](#fig3){ref-type="fig"}C, 3F, and 3I). Analysis of LGs 5 weeks after TM administration demonstrated clonal expansion of MEC with the largest clones consisting of 12--18 cells (7.7 ± 5.8, p \< 0.0001) ([Figures 3](#fig3){ref-type="fig"}D, 3G, and 3I) and with no labeling apparent on other cell types. Analysis of MEC clones following a 30-week chase period showed a variation of cell numbers in clones and the simultaneous existence of small (1--4 cells) ([Figures 3](#fig3){ref-type="fig"}E, 3H and 3I) and large (12--34 cells) clones (12 ± 13.4, p \< 0.0001) ([Figures 3](#fig3){ref-type="fig"}H and 3I). These findings, combined with Krt14 labeling and the detection of a subset of relatively slowly proliferating MECs, suggest that the MEC lineage may contain long-lived unipotent stem/progenitor cells capable of renewing the MEC pool throughout the organism\'s life.Figure 3MEC Cell Lineage Tracing in the LG of the *SMA*^*CreERT2*^*:R26-Confetti* Mice(A) Schematic diagram of the experimental design. *SMA*^*CreERT2*^*:R26-Confetti* mice were injected with TM at P14, and LGs were analyzed 1, 5, and 30 weeks later. Similarly, adult mice were injected with TM at P65, and LGs were excised and studied 1 and 15 weeks later.(B) Labeling efficiency after TM administration at P14 (determined in 1 week after TM injection).(C and F) Mosaic labeling of MECs 1 week after TM administration. (C) Low magnification image showing many labeled MECs. MECs still have an immature phenotype, i.e., their processes are short and thick (F).(D, E, G, and H) (D and G) After 5 weeks MECs form well-distinguishable clones. Thirty weeks later MEC clone size varies from being small (E and H, green clone), i.e., consisting of 1--5 cells, to large (H), consisting of 32--50 cells (red clone), suggesting the existence of short- and long-term proliferating cells within the MEC lineage.(I) Quantification of MEC clones after TM administration at P14. Results show mean ± SD, p \< 0.0001, as determined by the Wilcoxon-signed rank test.(J--M) (J) MECs labeled at P65 show mature phenotype but low labeling efficiency (K) (GFP \[bright green\], nuclear; YFP \[green\], cytoplasmic; and dsRed \[red\], cytoplasmic), as determined at 1 week after TM administration. 15 weeks after TM administration only small clones consisting of 1--4 cells were detected in adult *SMA*^*CreERT2*^*:R26-Confetti* mice (L and M). MECs in (L) were immunostained for αSMA.

MECs were also labeled in adult LGs at P65 and analyzed 1, 15, and 30 weeks later ([Figures 3](#fig3){ref-type="fig"}J--3L). In the adult LG only 6% ± 3% cells were labeled ([Figure 3](#fig3){ref-type="fig"}K), which allowed us to clearly distinguish each clone from its neighbors. After a 15-week chase only small clones containing 2--4 cells were detected ([Figure 3](#fig3){ref-type="fig"}L). However, labeled MECs were still found even after a 30-week chase ([Figure 3](#fig3){ref-type="fig"}M), again implying that the adult MEC lineage contains long-lived cells.

To determine whether embryonic MECs contribute to other cell lineages in adult LGs, pregnant *SMA*^*CreERT2/+*^:*R26-Tomato*^*fl/fl*^ females were injected with TM at E14.5--E15.0 and LGs were harvested following chase periods between 2 and 60 days ([Figure 4](#fig4){ref-type="fig"}A). At E17.0 (2-day chase), embryonic LGs demonstrated that SMA-expressing MEC progenitors originate from the external layer of cells within the developing epithelial bud ([Figures 4](#fig4){ref-type="fig"}B and 4C). All MEC progenitors typically had a cuboidal shape and did not display membrane processes ([Figures 4](#fig4){ref-type="fig"}B and 4C). At this stage labeling efficiency was high (98% ± 1.9%) as observed by immunostaining LGs at E19 with an αSMA antibody ([Figures 4](#fig4){ref-type="fig"}D--4G). Following a 4-day chase at E19, differentiating MECs formed small membrane protrusions ([Figures 4](#fig4){ref-type="fig"}I and 4J). Similar to LG epithelial cells, MEC progenitors expressed Pax6 ([Figures 4](#fig4){ref-type="fig"}H--4J, red arrows). During early postnatal development MECs continue to differentiate and form longer processes by P30 ([Figure 4](#fig4){ref-type="fig"}K); however, they remain to be associated with the maturating acinar component of the gland, as shown by labeling of ductal (Panx1) and acinar (Claudin1) compartments of the LG ([Figures 4](#fig4){ref-type="fig"}L and 4M). By the end of postnatal development, at approximately P30, MECs were fully differentiated into stellate cells with several long processes surrounding epithelial acini, and by P60, they form a continuous MEC network ([Video S1](#mmc2){ref-type="supplementary-material"}).Figure 4Analysis of MEC Lineage Using the *SMA*^*CreERT2*^*:R26-tdTomato* Mouse(A) Experimental design diagram. TM was administered during embryonic (E15) development, postnatal (P10/11) development, and adulthood (P27/28 and P60/61) and analyzed at variable times.(B and C) Labeled MECs were found in the external layer of cells of the LG buds (white arrow in C). They did not have processes and presented epithelial morphology.(D--G) (D) Labeling efficiency in the *SMA*^*CreERT2:*^*R26-tdTomato* mice, as determined by co-immunostaining with the SMA antibody at E19 (E--G) (n = 27; p \< 0.05, where n = number of glands).(H--J) At E19 MECs still remain to be associated with distal parts of LG epithelial tree (H) and mainly found within the LG buds (I), where they form small processes (J; white arrows). All epithelial cells, including MECs, express Pax6 (green) (J, red arrow: Pax6-expressing MEC).(K--M) (K) By P30 the labeled cells acquired a mature MEC phenotype, i.e., small cell body with several long processes. During postnatal development all MECs maintained close association with the maturating acinar component of the LG, as shown by immunostaining with the ductal marker Panx1 (L, green) and acinar marker Claudin 1 (M, green).(N and O) MECs and other epithelial cells proliferate during postnatal development, as shown by immunostaining with the anti phospho-histone H3 antibody (green; proliferating MECs, yellow arrowheads; proliferating acinar cells, white arrowheads). Insert in (N) shows proliferating MEC at higher magnification. (O) shows two proliferating MECs (yellow arrowheads) in one acinus.(P) Quantification of proliferating cells within different LG compartments (MEC, acinar, ductal, and mesenchymal \[mes\]). Results show mean ± SD, n = 56, ∗ p \< 0.05, two-tailed t test.(Q--S) MECs were labeled at P10/11 and quantified at P14 (Q) and P40 (S); quantification was performed using IMARIS software. Example is shown in (R).(T) Plot showing results of MEC quantification (n = 35, ∗ p \< 0.05, results show mean ± SD; two-tailed t test).(U) Similarly, MECs were labeled at P27/28 and quantified at P60 and P120. Number of MECs in the LG significantly increases by P60 but remains almost unchanged between P60 and P120 (n = 28; ∗p \< 0.05; results show mean ± SD; two-tailed t test).

Video S1. MECs form Continuous Network in Adult LG, Related to Figure 4MECs were genetically labeled, and their appearance has been analyzed in whole-mount preparations of adult LG.

Comparison of genetically labeled MECs in the αSma^CreERT2/+^:Rosa26-Tomato^fl/fl^ (C57BL/6 Strain) with the MECs stained with αSMA antibody in wild-type C57BL/6 strain showed similar MEC distribution and appearance (not shown). Next, we determined whether MECs proliferate during postnatal development. Cells were labeled at P10/11, and LGs were analyzed at P20. Proliferating cells were detected using an anti phospho-histone H3 antibody ([Figures 4](#fig4){ref-type="fig"}N and 4O). We found proliferating cells in all epithelial compartments ([Figures 4](#fig4){ref-type="fig"}N--4P), including acinar cells (3.7 ± 1.0), ductal cells (2.1 ± 0.9), and MECs (4.2 ± 2.2) of the LG and mesenchyme (1.5 ± 0.8).

We also determined whether there is an increase in the number of MECs compared with the number of nuclei during LG development and maturation. Cells were labeled by injecting mice with TM at P10/11 or P27/28, and the number of labeled MECs within at least 1,000 cells (number of labeled MECs per 1,000 nuclei) was calculated at P14 and P40 or P30, P60, and P120 correspondingly ([Figures 4](#fig4){ref-type="fig"}Q--4T and 4U). We found a substantial and statistically significant increase in MEC number during postnatal development and in early adulthood ([Figures 4](#fig4){ref-type="fig"}T and 4U); however, between P60 and P120 the number of MECs remained the same ([Figure 4](#fig4){ref-type="fig"}U). Thus, we established that SMA^+^ MECs proliferate but do not differentiate into any other cell types, suggesting that the SMA^+^ MEC lineage is distinct and established early in embryonic development.

The Lacrimal Gland of Adult Mice Contains αSMA-Negative Stem/Progenitor Cells Able to Differentiate into αSMA-Positive MECs {#sec2.4}
---------------------------------------------------------------------------------------------------------------------------

Our data support the hypothesis that under homeostatic conditions the αSMA^+^ MEC lineage in the LG is a distinct lineage, which is maintained by proliferating αSMA^+^ progenitors. To determine whether αSMA^+^ MEC lineage is really a distinct cell lineage in the LG thoughout whole mouse lifespan, we labeled cells by injecting α*SMA*^*CreERT2/+*^*:R26-Tomato*^*fl/fl*^ mice with TM at P14/15 and followed the MEC lineage for up to 24 months. We found that at P21 almost all labeled (dsRed^+^) MECs were also stained with αSMA antibody (99.3 ± 0.7, p \< 0.05, *n* = 15) ([Figures 5](#fig5){ref-type="fig"}A--5C and 5J). However, we observed a significant decrease in proportions of the αSMA^+^/dsRed^+^ MECs (66.8 ± 11.6, p \< 0.05, *n* = 12) after a 6- and (51.3 ± 5.7, p \< 0.05, *n* = 12) 24-month chase within the population of MECs stained with αSMA antibody ([Figure 5](#fig5){ref-type="fig"}J). Appearance of new unlabeled but SMA^+^ MECs was especially obvious at the distal parts of the LG, where gland growth occurs in adult mice (compare central parts of the LG [Figures 5](#fig5){ref-type="fig"}D--5F and distal parts of the gland [Figures 5](#fig5){ref-type="fig"}G--5I). The increasing number of unlabeled αSMA^+^/dsRed^−^ MECs observed after longer chase periods suggest that MEC progenitors that are negative for αSMA expression may indeed be present in adult LG.Figure 5Analysis of MEC Lineage in Adult and Aged SMA^CreERT2/+^:Rosa26-Tomato^fl/fl^ Mice(A--C) Co-immunostaining of MECs genetically labeled at P13/14 (red) with αSMA antibody (green) after 1 week of chase (P21). (A) Immunostaining with αSMA antibody. (B) Genetically labeled MECs. (C) Merged images.(D--I) Co-immunostaining of MECs labeled at P14 (red) with αSMA antibody (green) after 6 months of chase (P200). (D--F) Most of MECs in the proximal (central) part of the LG also labeled with the αSMA^+^ antibody (green), whereas the distal part of the LG contains labeled (red) and unlabeled (green) MECs (G--I).(J) Graphical representation of the results shown in (A--I). ∗n = 36; p \< 0.01; ∗∗n = 28, p \< 0.01, mean ± SD; two-tailed t test. Analysis of 14 LGs obtained from females, 7--12 sections per LG.(K and L) Number of labeled MECs decreases with age. TM was administered at P13/14, and a number of MECs were analyzed at 3 (K) and 24 months (L).(M) Quantification of the labeled MECs in the LGs after 3 and 24 months of chase. The number of labeled MECs is significantly decreased in aged mice. ∗Analysis of 15 LG obtained from 4 females aged 3 months old and 5 females aged 24 months (105 sections); p \< 0.05. Results show mean ± SD; two-tailed t test.

Next, we compared the number of labeled MEC cells between littermates labeled at P13/14 following 3 and 24 months after TM administration ([Figures 5](#fig5){ref-type="fig"}K and 5L). Quantification of labeled dsRed^+^ cells in the LG showed significant decrease in number of labeled cells in old compared with young mice ([Figure 5](#fig5){ref-type="fig"}M). At the same time a substantial number of labeled MECs were still present even after a 24-month chase, again suggesting that MEC progenitors are long-lived cells. Labeled cells were found only in the MEC lineage, suggesting that in the LG αSMA^+^ MEC lineage is a distinct cell lineage.

Lacrimal Gland SMA^+^ MEC Can Contribute to Epithelial Regeneration following IL-1α Injury {#sec2.5}
------------------------------------------------------------------------------------------

Although we did not observe SMA^+^ MECs giving rise to other epithelial cell types in the LG during development and homeostasis, we further challenged the system by injuring the gland with interleukin (IL)-1α administration. IL-1α injection induces a severe inflammatory response in the LG that leads to severe destruction of acinar cells in the injected LG lobules ([Figure S7](#mmc1){ref-type="supplementary-material"}), followed by gland regeneration in 7--14 days ([@bib53]). To follow the MEC fate after injury we labeled MECs in the *SMA*^*CreERT2/+*^:*R26-Tomato*^*fl/fl*^ mice at P28/30 (end of LG postnatal development, 6 mice, 2 experiments) or at P58/60 (adult LG, 12 mice, 4 experiments) by TM administration ([Figure 6](#fig6){ref-type="fig"}A), and 10 days later (at P40 or P75 correspondingly), the LG on one side of the animal was injected with saline (vehicle control) and the other was injured with IL-1α. Analysis of both the distribution and appearance of labeled cells was performed 2 weeks after injection (at P55 or P85) when LG regeneration is complete ([Figure 8](#fig8){ref-type="fig"}A). In control LGs (saline injected), all labeled cells had morphology and distribution characteristic of MECs and no other cell types were labeled ([Figures 6](#fig6){ref-type="fig"}B and 6C). In the glands injected with IL-1α, most labeled cells had MEC-like appearance; however, a small percent (9.8% ± 3.5% at P55 and 7.5% ± 4.4% at P85) of labeled acinar cells (i.e., of MEC origin) was found ([Figures 6](#fig6){ref-type="fig"}D--6F). These cells also highly expressed Panx1, which in the adult LG labels both acinar and ductal cells but has very low expression in MECs ([@bib5]). Taken together, these data demonstrate that following injury at least some of the MECs were able to contribute to the repair of another epithelial component and retain some plasticity throughout the life of the organism.Figure 6After LG Injury, MECs Repair the Acinar Epithelial Component(A) Experimental design diagram. In the injury experiments we used females because dry eye disease is prevalent in females and LGs in females are smaller, ensuring a significant LG damage (also see [Figure S7](#mmc1){ref-type="supplementary-material"}). The *SMA*^*CreERT2:*^*Rosa26-tdTomato* female mice were injected with TM for three consecutive days (at P28--P30 or P58--P60) to label MECs, and 10 days later the LGs on one side of the animal were injured by IL-1α, whereas LGs on the other side of the animal were injected with saline (vehicle control). At least two to four independent experiments were performed at each stage. Mice were sacrificed 2 weeks later, and LGs were processed for frozen section preparation, immunostaining, and analysis: P28--P55: two independent experiments, 6 mice; 6 control and 6 IL-1α-injected LGs were studied; P58--P85: four independent experiments, 12 mice, 12 control and 12 IL-1α-injected LGs were analyzed.(B--E) (B and C) In control (saline-injected) LG MECs retain an MEC phenotype and do not give rise to any other cell types, whereas after LG acute injury with IL-1α (D and E) a subset of MECs could acquire different fate and contribute to the acinar compartment of the LG.(F) Cell quantification for each condition in each experiment (control or injured) was performed in sections (5 random sections per gland with 5--7 fields per section were analyzed).Total number of labeled cells in each gland were considered 100%; acinar cells were immunostained with the Panx1 antibody (acinar and ductal marker in adult mice) and percentage of labeled acinar cells has been determined. ∗P28--P55: two-tailed t test n = 6, p \< 0.001 two-tailed t test; ∗∗P58--P85: n = 12, p \< 0.0001, two-tailed t test. All results show mean ± SD. See also [Figure S7](#mmc1){ref-type="supplementary-material"}.

Analysis of Runx1^+^ Cell Lineage {#sec2.6}
---------------------------------

We have previously demonstrated that the transcription factor Runx1 is expressed in the LG epithelium during development and marks ductal stem/progenitor cell compartments in the adult LG ([@bib44]). Using the TM-inducible *Runx1*^*MerCreMer*^*:R26-Confetti*^*fl/+*^ mouse, we traced Runx1^+^ lineage in the LG ([Figure 7](#fig7){ref-type="fig"}A). TM administration at E14-15 (one bud stage) revealed mosaic labeling of LG bud epithelium at E16-17 ([Figures 7](#fig7){ref-type="fig"}B and 7C). Next, we analyzed the population dynamics of Runx1-expressing cells after a longer chase period. Although the epithelial trees remained multicolored after a 5-week chase (at P30), discrete regions began to develop single-colored epithelial cell clones of all lineages ([Figure 7](#fig7){ref-type="fig"}D). Following a 9-week chase (at P60), large clones were detected in all LG compartments (ductal cells, acinar cells, and MEC) ([Figures 7](#fig7){ref-type="fig"}E--7G).Figure 7Runx1^+^ Embryonic Progenitors Give Rise to Multiple Cell Lineages, whereas Runx1-Expressing Cells in Late Postnatal Development Are Restricted to the Basal Ductal Cell Lineage(A) The Runx1 ^Mer−Cre-Mer/+^:R26-Confetti^fl/+^ mice were injected with tamoxifen (TM) at E15.5, and LGs were analyzed at E17, P30, P60, and P180.(B--F) (B and C) Mosaic labeling of epithelial cells at E17. At P30 (D) and P60 (E and F) cells labeled during embryogenesis form clones in all epithelial compartments of the LG.(G) Quantification of clone sizes over time after TM administration during embryonic development (cells were labeled at E17 and quantified at P60). 16 mice (LG from 10 females obtained from 3 litters were analyzed). Clonal size is represented by the mean of number of cells per clone ± SD.(H--J) TM administration during late postnatal development at P20 leads to labeling of cells mainly in basal ductal compartment. Only a few acinar cells were labeled.(K) Quantification of clone sizes over time in adult LG (cells were labeled at P20 and quantified at P180). Clonal size is represented by the mean of number of cells per clone ± SD.

In contrast, TM administration to *Runx1*^*MerCreMer*^*:R26-Confetti*^*fl/+*^ mice during late postnatal development (at P20/21) and analysis after 1.5 and 23 weeks of chase revealed labeling mostly within ducts (intercalated ducts and basal cells in inter- and intra-lobular ducts) with only a small proportion of cells labeled in the acinar cell compartment ([Figures 7](#fig7){ref-type="fig"}H--7K). These findings indicate that the lineage restriction of Runx1-expressing cells occurs rapidly after birth. Our data also suggest that during embryonic and maybe early postnatal development some epithelial progenitor cells are multipotent and can differentiate into several epithelial cell lineages; however, they become lineage-restricted during late postnatal development and in adulthood.

Expression Pattern of Stem/Progenitor Cell Markers in the Human LG {#sec2.7}
------------------------------------------------------------------

To determine the relevance of the data collated from our mouse models to humans, we analyzed the expression of several key transcription factors and other progenitor cell markers in human donor LGs. Thus, Pax6, a known marker of self-renewing epithelial progenitors, analogous to the mouse, was localized to distal epithelial cells ([Figure 8](#fig8){ref-type="fig"}A). Krt5 and Krt14 protein expression was also found in the epithelial component of human LG ([Figures 8](#fig8){ref-type="fig"}B, 8C, and [S8](#mmc1){ref-type="supplementary-material"}A--S8F). As shown by co-immunostaining with Krt14 ([Figures S8](#mmc1){ref-type="supplementary-material"}A--S8C), Krt5 ([Figures S8](#mmc1){ref-type="supplementary-material"}D--S8F), and αSMA antibody, high levels of Krt5 and Krt14 expression were found in the epithelial ducts and MECs, whereas Krt19, a marker of luminal ductal epithelia, was not expressed in the MEC ([Figures S8](#mmc1){ref-type="supplementary-material"}G--S8I). Sox9 was expressed in the nuclei of epithelial component of the gland ([Figures 8](#fig8){ref-type="fig"}D and 8E), and Sox10 was found only in a subset of epithelial cells ([Figure 8](#fig8){ref-type="fig"}F). Similar to the mice ([@bib16]), human THBS1 was expressed in the MECs and ducts ([Figure 8](#fig8){ref-type="fig"}H). Control IgGs did not show any staining ([Figure 8](#fig8){ref-type="fig"}G). Thus, human LGs show a high level of similarity to the mouse with regard to expression patterns of putative stem/progenitor cell and basal cell markers.Figure 8Expression of the Progenitor Cell Transcription Factors and Basal Cell Markers in Adult Human LGs(A--F) Similar to mouse LGs ([@bib28]), PAX6 (A) is expressed in the distal epithelial structures, whereas KRT5 (B) and KRT14 (C) are expressed in ductal epithelial derivates. SOX9 (D and E) is found in the nuclei of LG epithelium, whereas SOX10 (F) is restricted to the nuclei of acinar cells.(G) THBS1 is expressed in MECs (MECs, white arrows) and ducts (ducts, red arrows).(H) Negative control: section was treated with nonspecific IgG. Human LGs from three female donors (ages at the time of death were 62, 84, and 90 years) were obtained from Advanced Tissue Services (Phoenix, AZ, USA).See also [Figure S8](#mmc1){ref-type="supplementary-material"}.

Discussion {#sec3}
==========

In the current study, using cell lineage and LRC analysis we show the existence of a complex stem/progenitor cell hierarchy during LG development homeostasis and repair.

Herein, we demonstrated that during embryogenesis, the branching LG epithelium contains multipotent stem/progenitor cells able to give rise to several cell lineages ([Figures 9](#fig9){ref-type="fig"}A and [S9](#mmc1){ref-type="supplementary-material"}A). Based on our previous studies these multipotent cells may express several stem/progenitor cell markers such as Sox9, Pax6, Runx1, c-kit, and Krt5/14 ([@bib16], [@bib44]). Following birth, however, lineages become established and the fate of progenitor cell descendants becomes restricted ([Figures 9](#fig9){ref-type="fig"}B and [S9](#mmc1){ref-type="supplementary-material"}B). This was exemplified by Runx1^+^ embryonic progenitors that give rise to multiple cell lineages, whereas Runx1-expressing cells labeled in late postnatal development give rise mainly to the basal ductal cells. Moreover, Krt14-expressing cells labeled at early stages of postnatal development could be found in all lineages: MEC, basal ductal cells, and less frequently in acinar and luminal cells, whereas Krt14^+^ cells labeled in adult LGs give rise to only MEC and basal ductal cells. Our recent data suggest that partial specification of distal and proximal parts of the LG buds occurs sometime in embryonic development ([@bib41]) ([Figure 9](#fig9){ref-type="fig"}A). Farmer and coauthors ([@bib12]) suggest that ductal and acinar cells in the LG form unique populations by P4. In contrast, our current study and analysis of Sox10 mutant mouse ([@bib7]) suggest that the establishment of distal (MEC and acinar) and proximal (ductal) cell lineages may happen much earlier during embryonic development ([Figure 9](#fig9){ref-type="fig"}A). Thus distal parts of the developing LG buds are exposed to the mesenchymally expressed fibroblast growth factor-10 (Fgf10) ([@bib28], [@bib27]) that most likely controls Sox10 expression ([@bib7]) and the fate of acinar and MEC cells. Supporting this idea, our previous study showed that ectopic Fgf10 expression/application was able to induce an ectopic acinar cell formation in the cornea and conjunctiva ([@bib15], [@bib28]). However, it is still possible that a small number of multipotent epithelial progenitor cells exist in the LG during postnatal development and early adulthood.Figure 9Schematic Representation of the LG LineageMultipotent LG progenitor/stem cells exist in the embryonic LG and early postnatal development and give rise to all cell lineages.(A) Multipotent LG progenitor/stem cells co-express common markers identified early in LG development. The Sox10-negative cells give rise to ductal lineages, whereas Sox10-positive progenitor give rise to acinar and MEC lineages.(B and C) (B) Embryonic LG progenitor cells become predisposed toward one lineage as development proceeds and adopt specific marker profiles and location within the epithelium. This lineage restriction may happen at different time in each lineage. For example, MEC lineage is established very early during embryonic development (A), whereas ductal cell lineage is established later during postnatal development. At the same time unipotent MECs in postnatal and adult LGs have certain level of plasticity and may undergo *in vivo* reprogramming induced by LG injury (C). Thus, the MECs may have reserved MEC progenitors able to help with LG repair after injury (red arrow). (C) It is possible that common progenitor of MEC and acinar lineages is localized in the intercalated ducts (dashed arrow). Solid arrows, reported connections; dashed arrows, possible connections.See also [Figure S9](#mmc1){ref-type="supplementary-material"}.

Our current results correlate with data from other exocrine glands showing that lineage-restricted stem/progenitor cells sustain the development, long-term maintenance, and regeneration of specific cell lineages ([@bib3], [@bib10], [@bib42]).

Thus, in our model LG multipotent stem/progenitor cells differentiate during embryonic development into proximal Sox10^−^ and distal Sox10^+^ cell lineages ([Figure 9](#fig9){ref-type="fig"}A), which are further restricted into Sox10^−^ ductal (basal, luminal, and intercalated) and Sox10^+^ lineages (acinar and MEC) during early postnatal development ([Figure 9](#fig9){ref-type="fig"}B). However, it is indeed possible that cells retain some plasticity during adult life and may be able to transdifferentiate following injury ([Figure 9](#fig9){ref-type="fig"}C; indicated by red arrow).

Intriguingly, we found that LG SMA^+^ MEC lineage is established early in embryonic development ([Figures 4](#fig4){ref-type="fig"}B, 4C, and [9](#fig9){ref-type="fig"}A) and, similar to other glands ([@bib2]), originates from the external layer of cells within the distal bud and participates in postnatal LG growth expansion. These embryonic long-lived SMA^+^ MECs do not differentiate into cells of other lineages under homeostatic conditions. Moreover, analysis of SMA^+^ MEC clonal expansion in *SMA*^*CreERT2*^*:R26-Confetti* mice suggests the existence of two subpopulations of cells during postnatal development short-term and long-term MECs.

It has been previously suggested that the SMA^+^ MEC cell linage in adult LGs may contain multipotent SCs ([@bib37], [@bib38]). Furthermore, our group has observed a high degree of plasticity in both epithelial cells ([@bib16]) and MECs *in vitro*; however, the current investigation did not provide supporting evidence that this occurs *in vivo* under homeostatic conditions ([Figures 3](#fig3){ref-type="fig"} and [4](#fig4){ref-type="fig"}). Taken together with the observation that slow proliferating LRCs are not found in the MEC lineage following an 8-week chase period, it implies that the SMA^+^ MEC lineage in the LG is a distinct lineage that is maintained by proliferating lineage-restricted SMA^+^ progenitors originating from the distal layer of the epithelia within the LG bud during embryonic development. These SMA^+^ progenitors proliferate and differentiate during postnatal development in close association with LG acinar cells ([@bib5], [@bib12], [@bib26]). Embryonic ([@bib7], [@bib14]) and adult ([Figures S1](#mmc1){ref-type="supplementary-material"}I--S1K) acinar cells and MECs continue to express Sox10 in both the mouse and human ([Figure 8](#fig8){ref-type="fig"}F) LGs. Moreover, Sox10 knockout mice lose most of their acinar cells and all acini-associated MECs ([@bib7]). These findings support our proposition that the majority of acinar cells and MECs in the adult LG are direct descendants of a common Sox10^+^ acinar/MEC embryonic progenitor cell ([Figure 9](#fig9){ref-type="fig"}A). If development and differentiation of these common progenitors is perturbed during LG morphogenesis, other SCs/progenitor cells cannot completely replace lost cells from these compartments because the period of LG active expansion has already been completed.

Our label retention study using intrinsic genetic marking of LRCs showed the existence of slow-cycling stem/progenitor cells in the basal layer of the excretory ducts and in the intercalated ducts, further suggesting the existence of reserve cells in the LG. Whether common multipotent progenitors exist in adult LG still needs to be determined, as unique markers for this progenitor population are currently unknown. However, an increasing number of unlabeled MECs observed after longer chase periods of SMA^+^ MEC lineage suggests that MEC progenitors that are negative for αSMA expression may indeed be present in adult LG. At the same time our results also indicate that the majority of MECs in the LG are maintained by lineage-restricted SMA^+^ progenitors that exclusively contribute to the fast growth/expansion of the MEC lineage during postnatal development, whereas slow growth of adult homeostatic LG could be supported by both lineage-restricted SMA^+^ MEC progenitors and SMA^−^ common acinar/MEC cell progenitors. However, differentiated MECs retain some proliferative potential in adult uninjured LG ([@bib6], [@bib37]) and show a rapid proliferative response following gland injury ([@bib6]). We showed that SMA^+^ MECs retained plasticity *in vivo* and can differentiate into acinar cells after acute LG injury ([Figure 9](#fig9){ref-type="fig"}C). MEC plasticity has been reported in other glandular organs, such as mammary and submucosal glands, where they function as a reserve of stem/progenitor cells to regenerate tissue upon injury ([@bib25], [@bib30], [@bib40]). It is likely that in the LG, MECs perform a similar function, suggesting that in glandular organs, injury reveals the plasticity of unipotent progenitors and possibly differentiated MEC cells. Taken together our findings further support a model of lineage restriction of embryonic stem/progenitor cells in the early postnatal LGs and highlight extensive heterogeneity and selected redundancy within the adult LG progenitor cell pool. Similar findings were observed in the mammary gland (another exocrine gland) by molecular profiling and single-cell RNA sequencing, demonstrating that multipotent embryonic progenitor cells express a unique hybrid (basal and luminal) signature associated with different lineages ([@bib47]). Thus, our results and other publications support the notion that a developmental "switch" exists that restricts the multipotent activity of progenitor cells to unipotency or bipotency in various glandular tissues. However, the mechanism that controls the process of lineage restriction still needs to be elucidated.

Our Krt14 lineage data show the presence of another specialized basal ductal cell lineage ([Figure 9](#fig9){ref-type="fig"}C). One function of the multilayered excretory inter- and intra-lobular ducts in LGs is to maintain fluid propagation and to drain individual acini and lobes to maintain tear flow to the ocular surface. We found that a large subset of Krt14^+^ basal ductal cells continue to proliferate and differentiate into contractile basal ductal cells that possess small cell processes and contain filamentous actin (F-actin). The contractile function of basal ductal cells was reported by other investigators who showed tonofilaments within basal cells of LG ducts ([@bib21]). Thus, in adult LGs, the Krt14 cell lineage appears to be restricted to two contractile cells types, namely, MECs and basal ductal cells, which facilitate the release and circulation of the watery tears.

The longevity of the unipotent cells such as MECs and basal ductal progenitors, and their ability to participate in tissue regeneration, suggest the universal plasticity of these and possibly other cell types in the LG. The labeling patterns and analysis of injured LG suggest a model where injury/acute inflammation activates proliferation of the existing lineage-restricted progenitors, followed by the reserve progenitor cells and their progenies.

Comparison of stem/progenitor cell and basal markers in mouse and human LGs revealed a high level of similarity in their expression patterns. For example, as an important regulator of mouse LG development ([@bib7]) Sox9 labels all ductal cells and MECs, whereas Sox10 expression remains to be restricted to acinar cells and MECs. Similar patterns of Sox9 and Sox10 expression were found in human LGs ([Figures 8](#fig8){ref-type="fig"}D--8F). These findings suggest that the mouse and human LG may have similar mechanisms that control stem and progenitor cell function. Further analysis of mouse and human LGs would help to delineate the mechanism by which the progenitor cell pool is established and functions. This of course has far-reaching clinical implications. Recently, SC transplantation therapy has emerged as a promising method to treat both LGs and salivary gland disorders ([@bib10], [@bib13], [@bib16]). We and others have demonstrated that transplantation of putative epithelial progenitor cells isolated from "healthy" mouse LG or submandibular gland can restore function of the diseased organs, suggesting that stem/progenitor cells have a therapeutic role in ADDE ([@bib13], [@bib16]). However, efficiency of different types of stem/progenitor and different transplantation strategies remain to be resolved before successful clinical applications of the cell-based therapies are introduced to treat diseases that affect lacrimal and salivary glands.

In summary, LG lineage tracing has highlighted the existence of long-lived lineage-restricted unipotent and multipotent reserve cells that drive morphogenesis, homeostasis, and repair of the LG epithelial tree. Our findings provide important new details about glandular SC biology and reveal fundamental similarities and differences in the homeostatic and regenerative potential of stem and progenitor cells between LG and other glandular tissues.

Limitations of the Study {#sec3.1}
------------------------

Our genetic lineage-tracing studies in the mouse LG using K14, Runx1, and SMA (Acta2) drivers achieved *in vivo* permanent marking of specific populations of cells at specific stages of LG morphogenesis. Although analysis of these targeted cell populations provided us with valuable information on the LG epithelial differentiation hierarchy, these models have relied on prior assumptions regarding the specificity and consistency of the expression of the chosen gene promoters.

Resource Availability {#sec3.2}
---------------------

### Lead Contact {#sec3.2.1}

Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Helen P. Makarenkova (<hmakarenk@scripps.edu>).

### Materials Availability {#sec3.2.2}

Mouse lines generated in this study by breeding are available from the Lead Contact with a completed Materials Transfer Agreement.

### Data and Code Availability {#sec3.2.3}
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Methods {#sec4}
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All methods can be found in the accompanying [Transparent Methods supplemental file](#mmc1){ref-type="supplementary-material"}.
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